Relation between cardiac sympathetic activity and hypertensive left ventricular hypertrophy

Area of Science:

• Cardiology
• Hypertension Research
• Autonomic Nervous System Studies

Background:

• Left ventricular (LV) hypertrophy is a significant risk factor for cardiovascular events in hypertensive individuals.
• The role of sympathetic activation in the development of LV hypertrophy in humans requires further validation.

Purpose of the Study:

• To investigate and compare systemic and regional sympathetic activity in hypertensive patients with and without left ventricular hypertrophy.
• To determine the relationship between sympathetic activity and left ventricular mass in hypertension.

Main Methods:

• Utilized radiotracer dilution methods and microneurography to assess sympathetic activity.
• Compared three groups: hypertensive with LV hypertrophy (EH+), hypertensive without LV hypertrophy (EH-), and normotensive controls (NT).
• Measured LV mass index, total body and renal norepinephrine spillover, muscle sympathetic nerve activity, and cardiac norepinephrine spillover.

Main Results:

• Muscle sympathetic nerve activity and cardiac norepinephrine spillover were significantly elevated only in the hypertensive group with LV hypertrophy (EH+).
• Cardiac norepinephrine spillover showed a positive correlation with LV mass index across all subjects.
• While total body and renal norepinephrine spillover were higher in both hypertensive groups, cardiac-specific activity was uniquely increased in EH+.

Conclusions:

• Hypertensive left ventricular hypertrophy is associated with sympathetic activity predominantly localized to the heart.
• Increased cardiac norepinephrine release appears to be a key factor in the development of left ventricular hypertrophy in hypertensive patients.